AgingResearch.NewsJoin free

Naltrexone-bupropion

Naltrexone-bupropion has been studied in 10 papers since 2017: 1 observational study in people, 8 reviews; 3 in the past year. The newest paper, Nov 19, 2025: “From one-size-fits-all to phenotype-based pharmacotherapy: How far are we in obesity management?”.

Intervention

10 papers study itUpdated

See all 10 papers on naltrexone-bupropion

At a glance

5 trials, none about aging, 1 with no results posted.

Cells, worms or flies, mice and humans: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

About aging: the drug’s trials about aging. The total counts its trials for every use.

No results posted: trials that ended over a year ago with no results on ClinicalTrials.gov and no paper reporting them.

  • 5 trials, none about aging, 1 with no results posted
  • Humans1
  • In silico1

Has naltrexone-bupropion been tested in people?

0 of 5 about aging

Yes: 1 observational study in people have been published, and 5 trials are registered.

In trials

Stopped

  • NCT04531176TerminatedObesity

    After an unplanned yet IRB approved interim analysis, it was found that there was not a significant difference between the 3 arms of the study. The study was closed due to futility. All Patients are off study and this study will not resume.

Trial sponsors

Latest

Related